# FDA staff said their review of research found insufficient evidence to support semax’s use for the conditions in…
*Canonical page:* https://truthscore.com/claim/fda-staff-said-their-review-of-research-found-insufficient-evidence-to--07998ac3
*Numbers under lens:* **Evidence-weighted** (`log-odds@1`)
*Machine twins:* https://truthscore.com/claim/fda-staff-said-their-review-of-research-found-insufficient-evidence-to--07998ac3.md · JSON at https://truthscore.com/api/v1
FDA staff said their review of research found insufficient evidence to support semax’s use for the conditions in question.

## Voices

*Counted, never weighed.*

- [STAT](https://truthscore.com/entity/386551b8) — independent

## Sources

- [FDA advisory panel narrowly rejects compounding of one peptide, backs two others](https://truthscore.com/source/a99385d6)